Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 775 of 1,261

  1. US 8927506

    Acetates of 2-deoxy monosaccharides with anticancer activity

    The Board of Regents of the University of Texas System · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  2. US 8920625

    Electrochemical method of making porous particles using a constant current density

    The Board of Regents of the University of Texas System · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  3. US 8920373

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  4. US 8921396

    Crystalline freebase forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  5. US 8921395

    Crystalline forms of a biphenyl compound

    Theravance Biopharma R&D IP, LLC · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  6. US 8921376

    Pyrrolopyridines useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  7. US 8921371

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  8. US 8921393

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  9. US 8921379

    Fused ring compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  10. US 8921348

    Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  11. US 8921326

    Sustained-release composition and method for producing the same

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  12. US 8921335

    Oral delivery of nucleic acid-based gene interfering agents by Salmonella

    The Regents of the University of California · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  13. US 8921323

    Methods and compositions for modulating BCL-2 family polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  14. US 8921097

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  15. US 8920854

    Oral care compositions for treating xerostomia

    Georgia Regents Research Institute, Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  16. US 8921071

    Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  17. US 8920867

    Methods of forming self-supporting films for delivery of therapeutic agents

    Covidien LP · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  18. US 8920840

    Enteric tablet

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  19. US 8920800

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  20. US 8920848

    Use of cellular extracts for skin rejuvenation

    REGENICS AS · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  21. US 8920812

    Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

    Takeda Vaccines, Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  22. US 8920807

    Vault complexes for cytokine delivery

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  23. US 8920799

    Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  24. US 8921358

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.